Kids & teens (for parents) · Florida
Studies for children and teens in Florida
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
104 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Pfizer
- Location
- Orlando, FL + 11 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Jacksonville, FL + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Jacksonville, FL + 6 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals
- Location
- Miami, FL + 18 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic…
Takeda
- Location
- St. Petersburg, FL + 7 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Jacksonville, FL + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- Boca Raton, FL + 6 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Miami, FL + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 2/Phase 3
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- Jacksonville, FL + 3 other US sites
- Eligibility basics
- Ages 0 mo–17
- RecruitingPhase 3
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
AMAG Pharmaceuticals, Inc.
- Location
- Miami, FL + 2 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1/Phase 2
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)
Noveome Biotherapeutics, formerly Stemnion
- Location
- Tampa, FL + 7 other US sites
- Eligibility basics
- Ages 0 mo–2 mo
- RecruitingPhase 2
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
RECORDATI GROUP
- Location
- Cape Coral, FL + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Jacksonville, FL + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Doral, FL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
Amicus Therapeutics
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Pfizer
- Location
- Miami, FL + 4 other US sites
- Eligibility basics
- Ages 0 mo–17
- RecruitingPhase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
- Location
- Jacksonville, FL + 9 other US sites
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingPhase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Upsher-Smith Laboratories
- Location
- Tampa, FL + 5 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 1/Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
ViiV Healthcare
- Location
- Miami, FL + 5 other US sites
- Eligibility basics
- Ages 6–12
- RecruitingHealthy volunteers
Video Game Play to Alleviate Adolescent Anxiety
School of Health Sciences Geneva
- Location
- Miami, FL
- Eligibility basics
- Ages 11–15
- RecruitingHealthy volunteers
Almonds, Gut Microbiome and Kids
Florida State University
- Location
- Tallahassee, FL
- Eligibility basics
- Ages 6–13
- RecruitingHealthy volunteers
Pulse Education and Children
Florida State University
- Location
- Tallahassee, FL
- Eligibility basics
- Ages 6–13
- RecruitingHealthy volunteers
The Effects of Pacifier-Activated Lullaby on Oral Feeding Among Preterm Infants
Nemours Children's Clinic
- Location
- Orlando, FL
- Eligibility basics
- Ages 8 mo–8 mo
- RecruitingHealthy volunteers
Mental Health in Primary Care
University of Miami
- Location
- Miami, FL + 5 other US sites
- Eligibility basics
- Ages 12–16